Poststreptococcal glomerulonephritis

Last updated: February 23, 2023

Poststreptococcal glomerulonephritis

Watch later

Watch later

Myocardial infarction
Angina pectoris
Aortic dissection
Aneurysms
Shock
Cor pulmonale
Tricuspid valve disease
Pulmonary valve disease
Mitral valve disease
Aortic valve disease
Hypertrophic cardiomyopathy
Dilated cardiomyopathy
Restrictive cardiomyopathy
Pericarditis and pericardial effusion
Cardiac tamponade
Rheumatic heart disease
Endocarditis
Myocarditis
Premature ventricular contraction
Premature atrial contraction
Atrial fibrillation
Atrial flutter
Atrioventricular nodal reentrant tachycardia (AVNRT)
Wolff-Parkinson-White syndrome
Atrioventricular block
Bundle branch block
Long QT syndrome and Torsade de pointes
Ventricular tachycardia
Brugada syndrome
Ventricular fibrillation
Hypertension
Peripheral arterial disease (PAD): Nursing process (ADPIE)
Arterial disease
Vasculitis
Kawasaki disease
Behcet's disease
Deep vein thrombosis
Chronic venous insufficiency
Thrombophlebitis
Nutcracker syndrome
Superior mesenteric artery syndrome
Coronary steal syndrome
Lymphedema
Patent ductus arteriosus
Ventricular septal defect
Atrial septal defect
Coarctation of the aorta
Tetralogy of Fallot
Transposition of the great vessels
Persistent truncus arteriosus
Hypoplastic left heart syndrome
Vascular tumors
Arteriovenous malformation
Cardiac tumors
Angiosarcomas
Class I antiarrhythmics: Sodium channel blockers
Class II antiarrhythmics: Beta blockers
Class III antiarrhythmics: Potassium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
ACE inhibitors, ARBs and direct renin inhibitors
Miscellaneous lipid-lowering medications
Lipid-lowering medications: Fibrates
Lipid-lowering medications: Statins
Positive inotropic medications
Sympatholytics: Alpha-2 agonists
Adrenergic antagonists: Alpha blockers
Adrenergic antagonists: Beta blockers
Adrenergic antagonists: Presynaptic
cGMP mediated smooth muscle vasodilators
Calcium channel blockers
IgA nephropathy (NORD)
Rapidly progressive glomerulonephritis
Goodpasture syndrome
Poststreptococcal glomerulonephritis
Lupus nephritis
Minimal change disease
Nephrotic syndromes: Pathology review
Diabetic nephropathy
Membranoproliferative glomerulonephritis
Membranous nephropathy
Lower urinary tract infection
Acute pyelonephritis
Chronic pyelonephritis
Kidney stones
Renal tubular acidosis
Renal artery stenosis
Renal cortical necrosis
Renal azotemia
Postrenal azotemia
Chronic kidney disease
Hyponatremia
Hypernatremia
Hyperkalemia
Hypokalemia
Hypercalcemia
Hypocalcemia
Hypermagnesemia
Hypomagnesemia
Hyperphosphatemia
Hypophosphatemia
Neurogenic bladder
Urinary incontinence
Renal cell carcinoma
Angiomyolipoma
Nephroblastoma (Wilms tumor)
WAGR syndrome
Non-urothelial bladder cancers
Transitional cell carcinoma
Hydronephrosis
Vesicoureteral reflux
Posterior urethral valves
Bladder exstrophy
Polycystic kidney disease
Horseshoe kidney
Renal agenesis
Medullary sponge kidney
Multicystic dysplastic kidney
Medullary cystic kidney disease
Potter sequence
Parasympathetic nervous system
Central nervous system histology
Somatosensory pathways
Peripheral nervous system histology
Rheumatoid arthritis
Reactive arthritis
Psoriatic arthritis
Gout
Ankylosing spondylitis
Systemic lupus erythematosus
Scleroderma
Raynaud phenomenon
Limited systemic sclerosis (CREST syndrome)
Sjogren syndrome
Fibromyalgia
Polymyalgia rheumatica
Amyloidosis
Dermatomyositis
Polymyositis
Inclusion body myopathy
Osteoarthritis
Slipped capital femoral epiphysis
Paget disease of bone
Osteomalacia and rickets
Osteoporosis
Osgood-Schlatter disease (traction apophysitis)
Legg-Calve-Perthes disease
Septic arthritis
Osteomyelitis
Lordosis, kyphosis, and scoliosis
Rotator cuff tear
Meniscus tear
Compartment syndrome
Bone tumors
Developmental dysplasia of the hip
Cleidocranial dysplasia
Achondroplasia

Transcript

Watch video only

Content Reviewers

Poststreptococcal glomerulonephritis or PSGN is where the kidneys’ glomeruli, which is the location where small molecules are first filtered out of blood and into the urine, become inflamed after an infection by streptococcal bacteria.

Most commonly, PSGN starts with an infection by strains of group A beta-hemolytic streptococci bacteria, and this particular group of streptococcus has a specific antigen on its surface that lumps it into a group called “group A”.

This group A streptococci also produces an enzyme called streptolysin, and when the bacteria is grown on a petri dish of blood, the enzyme completely lyses red blood cells that are near the bacterial colony—called beta-hemolysis.

Beta-hemolysis is where they’re completely destroyed—as opposed to alpha-hemolysis, where cells aren’t actually destroyed, but they’re just damaged or bruised.

Additionally, these strains are considered nephritogenic strains because they carry the M-protein virulence factor, a protein that essentially helps them get around host defenses.

An infection by a nephritogenic strain of group A beta-hemolytic streptococcus bacteria initiates a type III hypersensitivity reaction, where immune complexes are formed, composed of antigens and antibodies, often IgG or IgM, that end up being carried in the bloodstream to the glomerulus and become trapped.

Specifically these deposits end up in the glomerular basement membrane or GBM, and most of the time they’re subepithelial, meaning between the epithelial cells, or podocytes, and the basement membrane.

It’s also possible the antigens from the bacteria are first trapped in the glomeruli, and then antibodies bind in the glomerulus itself.

Either way, these complexes initiate an inflammatory reaction in the glomerulus, which involves activation and deposition of C3 complement, inflammatory cytokines, oxidants, and proteases that all damage the podocytes.

This damage ends up allowing larger molecules to filter into the urine, like red blood cells and proteins, which then get into the urine and cause hematuria and proteinuria.

Those red blood cells in the urine actually often make it darker or cola-colored; also there tends to be less urine produced than normal, called oliguria.

Key Takeaways

Poststreptococcal glomerulonephritis (PSGN) is a type of glomerulonephritis that is caused by a reaction to group A Streptococcus bacterial infection. PSGN is usually a complication of skin bacterial infections, typically by Streptococcus, but can also occur after streptococcal pharyngitis. Symptoms of PSGN may include swelling of the face, hands, and feet; dark, and foamy urine. Treatment for PSGN may include antibiotics to treat the underlying infection, steroids to reduce inflammation, and dialysis to manage kidney failure.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  5. "Childhood post‐streptococcal glomerulonephritis as a risk factor for chronic renal disease in later life" Medical Journal of Australia (2001)
  6. "Bacterial infection–related glomerulonephritis in adults" Kidney International (2013)
  7. "Pathogenesis of poststreptococcal glomerulonephritis a century after Clemens von Pirquet" Kidney International (2007)